Does the FDA think these data justify the first full approval of a covid-19 vaccine?
Authors
Advisor
Date
2021-08-23
Embargo until
Language
Book title
Publisher
BMJ Publishing Group
Peer Reviewed
Type
Blog
Research Area
Jurisdiction
Collections
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
he FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines, says Peter Doshi
Citations
Altmetric: